Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-11-22

Clinical Trial Update: RCT for the Chinese Medicine in Treating Hypercholesterolemia [Phase 2]

View source ↗

Summary

A Phase 2 randomized trial evaluating a Chinese medicine formulation for hypercholesterolemia; the study is currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Unspecified Chinese medicine formulation

Snippet

Sponsor: Chinese University of Hong Kong | Conditions: Hypercholesterolemia | Phase 2 | Status: NOT_YET_RECRUITING